Cargando…
Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
PURPOSE: To evaluate the oncological outcomes and genitourinary and gastrointestinal adverse events in acute and late-phases of iodine-125 low-dose-rate brachytherapy for localized prostate cancer. MATERIAL AND METHODS: We retrospectively evaluated 334 patients treated for localized prostate cancer...
Autores principales: | Nakiri, Makoto, Ogasawara, Naoyuki, Kurose, Hirofumi, Ueda, Kosuke, Chikui, Katsuaki, Nishihara, Kiyoaki, Ejima, Kazuhisa, Uemura, Keiichiro, Murotani, Kenta, Muraki, Koichiro, Hattori, Chikayuki, Ogo, Etsuyo, Morimatsu, Yoshitaka, Ishitake, Tatsuya, Igawa, Tsukasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044300/ https://www.ncbi.nlm.nih.gov/pubmed/35494179 http://dx.doi.org/10.5114/jcb.2022.115380 |
Ejemplares similares
-
Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Nakiri, Makoto, et al.
Publicado: (2022) -
Seed lost to perineum from hydrogel spacer after brachytherapy for prostate cancer
por: Nakiri, Makoto, et al.
Publicado: (2023) -
Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
por: Muraki, Koichiro, et al.
Publicado: (2021) -
Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab
por: Ueda, Kosuke, et al.
Publicado: (2023) -
A Laparoscopic Management Combined with a Flexible Ureteroscope for Ureteral Polyps of More Than 3 cm Length
por: Matsuo, Mitsunori, et al.
Publicado: (2016)